SCAI 2023 Scientific Sessions
SCAI 2023 Scientific Sessions
Rob DillardSCAI 2023 Scientific Sessions | July 10, 2025
Ticagrelor monotherapy is linked with similar rates of recurrent coronary revascularization compared with standard therapy.
Read More
Rob DillardSCAI 2023 Scientific Sessions | July 10, 2025
Dr. George D. Dangas, about a study he led which analyzed the predictive value of the thrombotic risk criteria.
Rob DillardSCAI 2023 Scientific Sessions | July 10, 2025
Dr. Tanvir K. Bajwa talks about the FX TAVR system, designed to improve ease of use in coronary access.
Rob DillardSCAI 2023 Scientific Sessions | May 19, 2023
Pulmonary embolism patients treated with mechanical thrombectomy have improved outcomes and quality of life.
Rob DillardSCAI 2023 Scientific Sessions | July 10, 2025
Marijuana users incur more than three times the risk of developing peripheral artery disease.
Rob DillardSCAI 2023 Scientific Sessions | July 10, 2025
The novel Supira 10F system is a safe and effective percutaneous ventricular assist device for high-risk PCI.
Latest News
August 13, 2025